Dermal Irritation, Sensitization and Cumulative Irritation Potential of 6% Bemotrizinol
Clinical trial NCT05260359 · COMPLETED
Trial details
- NCT number
- NCT05260359
- Sponsor
- dsm-firmenich Switzerland AG
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-23
- Primary completion
- 2022-04-08
- Enrollment
- 224
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.